Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,044
Closed -$50K 473
2021
Q4
$50K Sell
1,044
-267
-20% -$13.4K 0.01% 402
2021
Q3
$73K Hold
1,311
0.01% 392
2021
Q2
$71K Hold
1,311
0.01% 390
2021
Q1
$74K Hold
1,311
0.01% 438
2020
Q4
$57K Buy
+1,311
New +$51.6K 0.01% 454
2020
Q3
Sell
-2,435
Closed -$105K 711
2020
Q2
$105K Buy
+2,435
New +$92.2K 0.01% 537
2018
Q4
Sell
-3,526
Closed -$263K 860
2018
Q3
$263K Buy
+3,526
New +$243K 0.01% 594
2017
Q1
Sell
-2,655
Closed -$67K 843
2016
Q4
$67K Sell
2,655
-1,719
-39% -$45.2K ﹤0.01% 743
2016
Q3
$132K Buy
4,374
+374
+9% +$10.3K ﹤0.01% 688
2016
Q2
$94K Hold
4,000
﹤0.01% 660
2016
Q1
$74K Sell
4,000
-8,500
-68% -$160K ﹤0.01% 663
2015
Q4
$253K Sell
12,500
-2,300
-16% -$48.8K 0.01% 538
2015
Q3
$323K Hold
14,800
0.01% 506
2015
Q2
$347K Sell
14,800
-2,800
-16% -$70.2K 0.01% 512
2015
Q1
$458K Sell
17,600
-200
-1% -$4.76K 0.01% 455
2014
Q4
$393K Sell
17,800
-4,200
-19% -$89K 0.01% 469
2014
Q3
$400K Buy
22,000
+4,000
+22% +$79.9K 0.01% 481
2014
Q2
$386K Sell
18,000
-4,100
-19% -$87.8K 0.01% 499
2014
Q1
$499K Sell
22,100
-6,700
-23% -$164K 0.01% 446
2013
Q4
$702K Sell
28,800
-6,600
-19% -$156K 0.02% 422
2013
Q3
$842K Sell
35,400
-8,100
-19% -$174K 0.02% 389
2013
Q2
$870K Buy
+43,500
New +$1.09M 0.02% 370

Other funds holding SRDX

First Quadrant's SRDX Position: Q1 2022 in Review

First Quadrant sold out of Surmodics (SRDX) in Q1 2022, closing a stake of 1,044 shares — an estimated $50K sold.

First Quadrant first reported a position in SRDX in Q2 2013 and held it in 22 quarters. The position peaked at $870K in Q2 2013. 135 funds tracked by Wall St. Rank hold SRDX as of Q1 2022.

  • First Quadrant reported no remaining Surmodics position as of Q1 2022 after selling out during the quarter.
  • First Quadrant sold 1,044 Surmodics shares in Q1 2022, an estimated $50K.
  • First Quadrant first reported a position in Surmodics in Q2 2013 and held it in 22 quarters.
  • First Quadrant's Surmodics position peaked at $870K in Q2 2013.
  • 135 funds tracked by Wall St. Rank held Surmodics as of Q1 2022.

Based on First Quadrant's 13F filing for Q1 2022, filed 21 Apr 2022.